Human infection studies: Key considerations for challenge agent development and production. (2022)

First Author: Balasingam S
Attributed to:  Human infection challenge vaccine (HIC-vac) network funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.12688/wellcomeopenres.17869.1

PubMed Identifier: 35505774

Publication URI: http://europepmc.org/abstract/MED/35505774

Type: Journal Article/Review

Volume: 7

Parent Publication: Wellcome open research

ISSN: 2398-502X